Feed Items
- previous post: Treatment-free remission after second-line nilotinib treatment in patients with chronic myeloid leukemia in chronic phase results from a single-group, phase 2, open-label study
- next post: Incidence and outcome of pericardial effusion in pediatric patients after hematopoietic stem cell transplant: A single-institution experience